Blue Cross and Blue Shield of North Carolina expands specialty pharmacy precertification list (Healthy Blue + Medicare HMO-DSNP)

September 02, 2022
group-label
Button Group
size
md
orientation
horizontal
alignment
center
button-type
lh-button
variant
text
text
Pharmacy
media-label
label
link
Pharmacy
icon-position
right
full-width
false
full-width-mobile
false
button-type
lh-button
variant
text
text
Blue Medicare
media-label
label
link
Blue Medicare
icon-position
right
full-width
false
full-width-mobile
false

Please note, this communication applies to Healthy Blue + Medicare℠ (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina (Blue Cross NC).

Effective for dates of service on and after December 1, 2022, the specialty Medicare part B drug listed in the table below will be included in our precertification review process.

Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

lh-header-fill
true
lh-sticky-header-column
true
HCPCS or CPT® codes Medicare part B drugs
J3490, J3590 Amvuttra (vutrisiran)
J3299 Xipere (triamcinolone acetonide injectable suspension)

For more information, visit Healthy Blue + Medicare

NCBCBS-CR-005193-22-CPN4920 August 2022